Blockbuster drug

Jump to: navigation, search

A blockbuster drug is a drug generating more than $1 billion of revenue for its owner each year. The search for blockbusters has been the foundation of the R&D strategy adopted by big pharmaceutical companies, but this looks set to change. New advances in genomics, and the promise of personalized medicine, are likely to fragment the pharmaceutical market.

A recent report from Urch Publishing estimated that about one third of the pharma market by value is accounted for by blockbusters. About 100 products are blockbusters. The top seller was Lipitor a cholesterol-lowering medication marketed by Pfizer with sales of $12.2 billion.

Leading blockbuster drugs

Further reading

Pharmaceutical Market Trends, 2006-2010, from Urch Publishing [1]

Blockbuster Drugs 2006: Executive Overview, from Report Buyer[2]



Linked-in.jpg